Skip to content

Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range

Use of Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range During Major Surgery: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03816514
Enrollment
130
Registered
2019-01-25
Start date
2019-03-04
Completion date
2020-11-06
Last updated
2020-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion, Hemoglobins, Hemorrhage

Brief summary

The primary aim of this study is to evaluate whether pulse oximetry based noninvasive hemoglobin (SpHb) monitoring can reduce the incidence of hemoglobin (Hb) level out of the target range in adult patients undergoing major surgery with the potential risk of bleeding.

Interventions

Noninvasive, continuous pulse oximetry-based hemoglobin (SpHb) monitoring

Conventional management without SpHb monitoring

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with ASA physical status class I, II, III, who scheduled to undergo elective non-cardiac major surgery with more than moderate risk of bleeding under general anesthesia or spinal anesthesia. * Eligible Surgery include: Spine surgery, bone tumor surgery, Total Hip Replacement, ovarian cancer surgery, cervical cancer surgery, radical cystectomy, open retroperitoneal mass excision, Radical Retropubic Prostatectomy, explorative laparotomy for abdominal mass excision, abdominal aortic aneurysm repair * Patients who are requiring an arterial catheter as a part of their standard care.

Exclusion criteria

* Patients with preexisting deformity or skin condition that would impede sensor placement * Patients with allergies to the adhesive sensor material * Patients with uncorrected preoperative anemia (preoperative hemoglobin \< 7 g/dL) * Patients who were not suitable for participation in the opinion of the study investigator.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of deviation from the target hemoglobin rangeUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia(The number of laboratory samples with the result hemoglobin concentrations were out of the target range)/(Total number of laboratory samples that performed during intra-operative periods)

Secondary

MeasureTime frameDescription
Number of Point-of-care (POC) sampling during surgeryUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaNumber of Point-of-care (POC) sampling for measurement of hemoglobin concentration. In SpHb group, POC sampling will be done according to SpHb level. In control group, POC sampling will be done at discretion of anesthesiologist.
Accuracy of the SpHb valueUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaStandard Laboratory hemoglobin measurement will be used as reference. Laboratory measurements will be done every 30 minute during surgery
Number of patients who receive intra-operative transfusionUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaNumber of patients who were transfused with pRBCs intraoperatively
Total volume of intravenous fluids givenUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaTotal volume of intravenous fluids given intra-operatively
The percentage extent of deviation from the target hemoglobin rangeUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaThe percentage extent of deviation of laboratory hemoglobin out of the prespecified target range
Time for transfusion delayUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaTime from the determination of transfusion to actual transfusion, in minutes
Incidence of intraoperative hypotensionUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiahypotension is defined as SBP \< 80% of baseline SBP
laboratory total hemoglobin value, at postoperative day 1at postoperative day 1total hemoglobin value measured by standard laboratory method
Total volume of pRBCs transfusedUntil transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesiaTotal volume of pRBCs transfused intra-operatively

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026